Clinical trial
Study of Combination PS-341 and Thalidomide in Multiple Myeloma
NCT00083460 · University of Arkansas, Other · Completed
Key facts
| NCT number | NCT00083460 |
|---|---|
| Title | Study of Combination PS-341 and Thalidomide in Multiple Myeloma |
| Official title | UARK 2001-37, A Phase I Exploratory Study of Combination PS-341 and Thalidomide in Refractory Multiple Myeloma |
| Lead sponsor | University of Arkansas, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | PS-341, Thalidomide, Dexamethasone |
| Enrollment | 86 |
| Start date | Dec 1, 2001 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | May 26, 2004 |
| Last update posted | Aug 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: